Graadal O, Schlichting E, Aasen A O, Stadaas J O
Kirurgisk avdeling, Ullevål sykehus, Oslo.
Tidsskr Nor Laegeforen. 1990 Sep 30;110(23):2981-2.
We calculated the costs of surgery for pancreatic cancer in 151 patients treated for carcinoma of the pancreas at Ullevål sykehus, University of Oslo, during the period 1980-89. The costs of the diagnostic process and the hospital stay were calculated separately. We found that radical surgery cost about NOK 80,000 more than a palliative operation. The median survival time after radical operation was only 11 months, compared with five months after palliative surgery. We are discussing the price of the surgery in relation to the results. We stress the importance of restrictive selection criteria for radical surgery of pancreatic cancer and conclude that the higher cost of radical surgery as compared with palliative procedures is acceptable.
我们计算了1980年至1989年期间在奥斯陆大学乌勒瓦尔医院接受胰腺癌治疗的151例患者的胰腺癌手术费用。诊断过程和住院费用分别进行了计算。我们发现，根治性手术的费用比姑息性手术高出约80,000挪威克朗。根治性手术后的中位生存时间仅为11个月，而姑息性手术后为5个月。我们正在讨论手术费用与治疗结果的关系。我们强调了胰腺癌根治性手术严格选择标准的重要性，并得出结论，与姑息性手术相比，根治性手术较高的费用是可以接受的。
